In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy?
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy?
Authors
Keywords
-
Journal
BJU INTERNATIONAL
Volume 115, Issue 4, Pages 562-570
Publisher
Wiley
Online
2014-09-23
DOI
10.1111/bju.12938
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Defining the learning curve for multiparametric magnetic resonance imaging (MRI) of the prostate using MRI-transrectal ultrasonography (TRUS) fusion-guided transperineal prostate biopsies as a validation tool
- (2015) Gabriele Gaziev et al. BJU INTERNATIONAL
- Multiparametric magnetic resonance imaging outperforms the Prostate Cancer Prevention Trial risk calculator in predicting clinically significant prostate cancer
- (2014) Simpa S. Salami et al. CANCER
- Evolution of repeat prostate biopsy strategies incorporating transperineal and MRI–TRUS fusion techniques
- (2014) Timur H. Kuru et al. WORLD JOURNAL OF UROLOGY
- Prostate cancer: summary of updated NICE guidance
- (2014) J. Graham et al. BMJ-British Medical Journal
- The cost implications of prostate cancer screening in the Medicare population
- (2013) Xiaomei Ma et al. CANCER
- A Prospective, Blinded Comparison of Magnetic Resonance (MR) Imaging–Ultrasound Fusion and Visual Estimation in the Performance of MR-targeted Prostate Biopsy: The PROFUS Trial
- (2013) James S. Wysock et al. EUROPEAN UROLOGY
- Early Detection of Prostate Cancer: AUA Guideline
- (2013) H. Ballentine Carter et al. JOURNAL OF UROLOGY
- Improving Detection of Clinically Significant Prostate Cancer: Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Guided Prostate Biopsy
- (2013) Ardeshir R. Rastinehad et al. JOURNAL OF UROLOGY
- Repeat Prostate Biopsy Strategies after Initial Negative Biopsy: Meta-Regression Comparing Cancer Detection of Transperineal, Transrectal Saturation and MRI Guided Biopsy
- (2013) Adam W. Nelson et al. PLoS One
- The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level—Can it rule out clinically significant prostate cancer?
- (2013) Mohamed Abd-Alazeez et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- ESUR prostate MR guidelines 2012
- (2012) Jelle O. Barentsz et al. EUROPEAN RADIOLOGY
- Multiparametric Magnetic Resonance Imaging and Ultrasound Fusion Biopsy Detect Prostate Cancer in Patients with Prior Negative Transrectal Ultrasound Biopsies
- (2012) Srinivas Vourganti et al. JOURNAL OF UROLOGY
- Prebiopsy Magnetic Resonance Imaging and Prostate Cancer Detection: Comparison of Random and Targeted Biopsies
- (2012) Nicolas Barry Delongchamps et al. JOURNAL OF UROLOGY
- Increasing Hospital Admission Rates for Urological Complications After Transrectal Ultrasound Guided Prostate Biopsy
- (2012) Robert K. Nam et al. JOURNAL OF UROLOGY
- Prostate cancer detection after a negative prostate biopsy: Lessons learnt in the Cleveland Clinic experience
- (2011) Osama M Zaytoun et al. INTERNATIONAL JOURNAL OF UROLOGY
- D'Amico Risk Stratification Correlates With Degree of Suspicion of Prostate Cancer on Multiparametric Magnetic Resonance Imaging
- (2011) Ardeshir R. Rastinehad et al. JOURNAL OF UROLOGY
- Complications After Prostate Biopsy: Data From SEER-Medicare
- (2011) Stacy Loeb et al. JOURNAL OF UROLOGY
- Magnetic Resonance Imaging/Ultrasound Fusion Guided Prostate Biopsy Improves Cancer Detection Following Transrectal Ultrasound Biopsy and Correlates With Multiparametric Magnetic Resonance Imaging
- (2011) Peter A. Pinto et al. JOURNAL OF UROLOGY
- Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer
- (2011) Simpa S. Salami et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- PCA3 Molecular Urine Test for Predicting Repeat Prostate Biopsy Outcome in Populations at Risk: Validation in the Placebo Arm of the Dutasteride REDUCE Trial
- (2010) Sheila M.J. Aubin et al. JOURNAL OF UROLOGY
- The Effect of Dutasteride on the Usefulness of Prostate Specific Antigen for the Diagnosis of High Grade and Clinically Relevant Prostate Cancer in Men With a Previous Negative Biopsy: Results From the REDUCE Study
- (2010) Gerald L. Andriole et al. JOURNAL OF UROLOGY
- Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy
- (2008) Alexander Haese et al. EUROPEAN UROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started